Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they controlEmanuele de Rinaldis, Andrew Tutt, Cheryl Gillett et al.|BMC Genomics|2013Cited by 87
The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motilityTai Kiuchi, Tony Ng, Elena Ortíz-Zapater et al.|Science Signaling|2014Cited by 63
Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survivalFilipe Grácio, Emanuele de Rinaldis, Brian Burford et al.|Scientific Reports|2017Cited by 14